CD8A and neoplasm: Previous research has found that high expression levels of CX3CL1 in tumor cells can induce tumor-infiltrating CD8+ T cells, dendritic cells, and activated natural killer cells to exert antitumor immune activity, thus inhibiting tumor growth [26, 27].